Global Influenza Diagnostics Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

MarketResearch.biz delivers in-depth insights on the global influenza diagnostics market in its upcoming report titled, “Global Influenza Diagnostics Market Trends, Analysis, Growth, and Forecast: 2018 to 2027”. The global influenza diagnostics market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global influenza diagnostics market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global influenza diagnostics market, their financials, supply chain trends, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global influenza diagnostics market report has been segmented on the basis of test type, end user, and region.

Request Covid - 19 Impact

Influenza, commonly known as flu, is a contagious illness caused by influenza virus. Symptoms could be mild or severe. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. However, with an accurate and timely diagnosis, and appropriate treatment the patient infected with influenza virus can be cured. Furthermore, early diagnosis reduces the inappropriate use of antibiotics.

Increasing prevalence of influenza globally is expected to result in rising demand for influenza diagnosis. In addition, increasing focus by government to prevent and control influenza are other factors contributing to growth of the global influenza diagnostics market. Moreover, rising awareness about the influenza globally is anticipated to further drive growth of the global influenza diagnostics market over the forecast period.

Increasing prices for kits and reagents for diagnosis is considered as a major factor restraining growth of the global influenza diagnostics market.

However, technological advancements and innovations focusing on developing faster, accurate, and cost-effective diagnosis for disease is expected to create new opportunities for major players in the global influenza diagnostics market over the forecast period.

North America market dominates the global influenza diagnostics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and governments taking initiative to prevent and control infectious disease in the region. Europe market accounts for second-largest revenue share contribution to the global influenza diagnostics market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to higher disease burden, and prevalence of influenza disease in this region.

Global Influenza Diagnostics Market Segmentation:

Global influenza diagnostics market segmentation by test type:

• Reverse transcription polymerase chain reaction (RT-PCR)
• Rapid Antigen Testing
• Cell Culture
• Others (Immunofluorescence & Serology)

Global influenza diagnostics market segmentation by end user:

• Hospitals
• Laboratories
• Point of care testing centres (POCT)

Global influenza diagnostics market segmentation, by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa